496 related articles for article (PubMed ID: 27325693)
1. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M Induces Lipolysis and Suppresses Insulin Response in 3T3-L1 Adipocytes.
Bailey JL; Hang H; Boudreau A; Elks CM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563078
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation.
Sanchez-Infantes D; Stephens JM
Front Immunol; 2020; 11():612013. PubMed ID: 33854494
[TBL] [Abstract][Full Text] [Related]
4. Adipose Tissue Dysfunction Occurs Independently of Obesity in Adipocyte-Specific Oncostatin Receptor Knockout Mice.
Stephens JM; Bailey JL; Hang H; Rittell V; Dietrich MA; Mynatt RL; Elks CM
Obesity (Silver Spring); 2018 Sep; 26(9):1439-1447. PubMed ID: 30226002
[TBL] [Abstract][Full Text] [Related]
5. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M Mediates Adipocyte Expression and Secretion of Stromal-Derived Factor 1.
Hang H; Bailey JL; Elks CM
Biology (Basel); 2019 Mar; 8(1):. PubMed ID: 30909581
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.
Sanchez-Infantes D; White UA; Elks CM; Morrison RF; Gimble JM; Considine RV; Ferrante AW; Ravussin E; Stephens JM
J Clin Endocrinol Metab; 2014 Feb; 99(2):E217-25. PubMed ID: 24297795
[TBL] [Abstract][Full Text] [Related]
8. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
[TBL] [Abstract][Full Text] [Related]
9. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
[TBL] [Abstract][Full Text] [Related]
11. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
12. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.
Nishimoto S; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Murata C; Kim-Kaneyama JR; Sato F; Bando M; Yagi S; Soeki T; Hayashi T; Imoto I; Sakaue H; Shimabukuro M; Sata M
Sci Adv; 2016 Mar; 2(3):e1501332. PubMed ID: 27051864
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling.
van Krieken PP; Odermatt TS; Borsigova M; Blüher M; Wueest S; Konrad D
Mol Metab; 2021 Dec; 54():101341. PubMed ID: 34547509
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M pathway plays a major role in the renal acute phase response.
Luyckx VA; Cairo LV; Compston CA; Phan WL; Mueller TF
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F875-83. PubMed ID: 19158344
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2014 May; 289(20):13821-37. PubMed ID: 24695736
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
17. Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.
Jakob L; Müller TA; Rassner M; Kleinfelder H; Veratti P; Mitschke J; Miething C; Oostendorp RAJ; Pfeifer D; Waterhouse M; Duyster J
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769079
[TBL] [Abstract][Full Text] [Related]
18. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth.
Geethadevi A; Nair A; Parashar D; Ku Z; Xiong W; Deng H; Li Y; George J; McAllister DM; Sun Y; Kadamberi IP; Gupta P; Dwinell MB; Bradley WH; Rader JS; Rui H; Schwabe RF; Zhang N; Pradeep S; An Z; Chaluvally-Raghavan P
Cancer Res; 2021 Oct; 81(20):5336-5352. PubMed ID: 34380633
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin ligase Siah2 regulates obesity-induced adipose tissue inflammation.
Kilroy G; Carter LE; Newman S; Burk DH; Manuel J; Möller A; Bowtell DD; Mynatt RL; Ghosh S; Floyd ZE
Obesity (Silver Spring); 2015 Nov; 23(11):2223-32. PubMed ID: 26380945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
